Sarepta Therapeutics (SRPT) Interest & Investment Income (2010 - 2022)
Sarepta Therapeutics' quarterly Interest & Investment Income came in at $9.1 million in Q4 2022, up 9506.32% year-on-year from $95000.0 in Q4 2021, and up 90.92% quarter-over-quarter from $4.8 million in Q3 2022.
Sarepta Therapeutics has reported Interest & Investment Income for 10 years, with the latest figure at $9.1 million in Q4 2022.
- For the quarter ending Q4 2022, Interest & Investment Income rose 9506.32% year-over-year to $9.1 million; the trailing twelve-month figure through Dec 2022 stood at $16.5 million (up 4557.63% YoY), and the FY2023 full-year result was $36.3 million, up 119.9% from the prior year.
- Interest & Investment Income for Q4 2022 stood at $9.1 million, up from $4.8 million in the prior quarter.
- The five-year high for Interest & Investment Income was $9.1 million in Q4 2022, with the low at -$7.0 million in Q3 2018.
- Average Interest & Investment Income over 5 years is $403400.0, with a median of $160500.0 recorded in 2021.
- Year-over-year, Interest & Investment Income slumped 3886.96% in 2018 and jumped 9506.32% in 2022.
- Tracing SRPT's Interest & Investment Income over 5 years: stood at -$2.3 million in 2018, then soared by 164.04% to $1.5 million in 2019, then sank by 95.2% to $71000.0 in 2020, then soared by 33.8% to $95000.0 in 2021, then jumped by 9506.32% to $9.1 million in 2022.
- The last three Interest & Investment Income figures came in at $9.1 million (Q4 2022), $4.8 million (Q3 2022), and $2.4 million (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 9.13 Mn |
| Sep 30, 2022 | 4.78 Mn |
| Jun 30, 2022 | 2.41 Mn |
| Mar 31, 2022 | 173,000.00 |
| Dec 31, 2021 | 95,000.00 |
| Sep 30, 2021 | 148,000.00 |
| Jun 30, 2021 | 52,000.00 |
| Mar 31, 2021 | 59,000.00 |
| Dec 31, 2020 | 71,000.00 |
| Sep 30, 2020 | 122,000.00 |
| Jun 30, 2020 | 638,000.00 |
| Mar 31, 2020 | 2.14 Mn |
| Dec 31, 2019 | 1.48 Mn |
| Sep 30, 2019 | 1.29 Mn |
| Jun 30, 2019 | 2.10 Mn |
| Mar 31, 2019 | 2.36 Mn |
| Dec 31, 2018 | -2.31 Mn |
| Sep 30, 2018 | -6.97 Mn |
| Jun 30, 2018 | -5.22 Mn |
| Mar 31, 2018 | -4.49 Mn |
| Dec 31, 2017 | -2.69 Mn |
| Sep 30, 2017 | 184,000.00 |
| Jun 30, 2017 | 184,000.00 |
| Mar 31, 2017 | 335,000.00 |
| Sep 30, 2013 | 63,000.00 |
| Jun 30, 2013 | -19,000.00 |
| Mar 31, 2013 | 237,000.00 |
| Dec 31, 2012 | 83,000.00 |
| Sep 30, 2012 | 67,000.00 |
| Jun 30, 2012 | 107,000.00 |
| Mar 31, 2012 | 96,000.00 |
| Dec 31, 2011 | 147,000.00 |
| Sep 30, 2011 | 199,000.00 |
| Jun 30, 2011 | 151,000.00 |
| Mar 31, 2011 | 90,000.00 |
| Dec 31, 2010 | 89,000.00 |
| Sep 30, 2010 | 82,000.00 |
| Jun 30, 2010 | 51,000.00 |